{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:08:36Z","timestamp":1749636516518,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T00:00:00Z","timestamp":1462147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12094-016-1511-3","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T09:14:15Z","timestamp":1462180455000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Utility of 18F-FDG-PET\/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-6813","authenticated-orcid":false,"given":"F. J.","family":"Pena Pardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Garc\u00eda Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amo-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"L\u00f3pez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Garrido Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. \u00c1.","family":"de Ayala Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"del Saz Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mu\u00f1oz Pasadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,2]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.","journal-title":"Lancet Neurol."},{"key":"1511_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, Gilhusd NE, Giometto F, Graus F, et al. European federation of neurological societies. screening for tumors in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18:19\u201323.","journal-title":"Eur J Neurol."},{"key":"1511_CR3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.14141073","volume":"274","author":"JR Lee","year":"2015","unstructured":"Lee JR, Kim JS, Roh JL, Lee JH, Baek JH, Cho KJ, et al. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG-PET\/CT with contrast-enhanced CT or CT\/MR imaging-prospective study. Radiology. 2015;274:764\u201371.","journal-title":"Radiology."},{"key":"1511_CR4","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.28229","volume":"133","author":"A Alfonso","year":"2013","unstructured":"Alfonso A, Redondo M, Rubio T, Del Olmo B, Rodr\u00edguez-Wilhelmi P, Garc\u00eda-Velloso MJ, et al. Screening for occult malignancy with FDG- PET\/CT in patients with unprovoked venous thromboembolism. Int J Cancer. 2013;133:2157\u201364.","journal-title":"Int J Cancer."},{"key":"1511_CR5","volume-title":"Should PET\/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma?","author":"J Cacicedo","year":"2015","unstructured":"Cacicedo J, Fernandez I, Del Hoyo O, Dolado A, G\u00f3mez-Suarez J, Hortelano E, et al. Should PET\/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma?. Eur J Nucl Med Mol Imaging.: A prospective analysis; 2015 (Epub ahead of print)."},{"issue":"30","key":"1511_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3803\/EnM.2015.30.1.71","volume":"27","author":"AR Chun","year":"2015","unstructured":"Chun AR, Jo HM, Lee SH, Chun HW, Park JM, Kim KJ, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Endocrinol Metab (Seoul). 2015;27(30):71\u20137.","journal-title":"Endocrinol Metab (Seoul)."},{"key":"1511_CR7","first-page":"24","volume":"34","author":"F Bertagna","year":"2015","unstructured":"Bertagna F, Evangelista L, Piccardo A, Bertoli M, Bosio G, Giubbini R, et al. Multicentric study on 18F-FDG-PET\/CT breast incidental uptake in patients studied for non-breast malignant purposes. Rev Esp Med Nucl Imagen Mol. 2015;34:24\u20139.","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"1511_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2478\/raon-2013-0035","volume":"48","author":"G Treglia","year":"2014","unstructured":"Treglia G, Taralli S, Salsano M, Muoio B, Sadeghi R, Giovanella L. Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET\/CT: a meta-analysis. Radiol Oncol. 2014;48:99\u2013104.","journal-title":"Radiol Oncol."},{"key":"1511_CR9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/brain\/124.11.2223","volume":"124","author":"JH Rees","year":"2001","unstructured":"Rees JH, Hain SF, Johnson MR, Hughes RA, Costa DC, Ell PJ, et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain. 2001;124:2223\u201331.","journal-title":"Brain."},{"key":"1511_CR10","first-page":"85","volume":"47","author":"U Berner","year":"2003","unstructured":"Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, D\u00f6bert N, et al. Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET. Q J Nucl Med. 2003;47:85\u20139.","journal-title":"Q J Nucl Med"},{"key":"1511_CR11","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","volume":"127","author":"S Younes-Mhenni","year":"2004","unstructured":"Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumor detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127:2331\u20138.","journal-title":"Brain."},{"key":"1511_CR12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","volume":"63","author":"R Linke","year":"2004","unstructured":"Linke R, Schroeder M, Helmberger T, Voltz R. Antibody-positive paraneoplastic neurologic syndromes; value of CT and PET for tumor diagnosis. Neurology. 2004;63:282\u20136.","journal-title":"Neurology"},{"key":"1511_CR13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0025-6196(11)60768-4","volume":"83","author":"RR Patel","year":"2008","unstructured":"Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008;83:917\u201322.","journal-title":"Mayo Clin Proc"},{"key":"1511_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-540-31203-1_16","volume":"170","author":"R Linke","year":"2008","unstructured":"Linke R, Voltz R. FDG-PET in paraneoplastic syndromes. Recent Results Cancer Res. 2008;170:203\u201311.","journal-title":"Recent Results Cancer Res"},{"key":"1511_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0404.2008.01089.x","volume":"119","author":"M Hadjivassiliou","year":"2009","unstructured":"Hadjivassiliou M, Alder SJ, Van Beek EJ, Hanney MB, Lorenz E, Rao DG, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186\u201393.","journal-title":"Acta Neurol Scand"},{"key":"1511_CR16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000312657","volume":"78","author":"C Sioka","year":"2010","unstructured":"Sioka C, Fotopoulos A, Kyritsis AP. Paraneoplastic neurological syndromes and the role of PET imaging. Oncology. 2010;78:150\u20136.","journal-title":"Oncology."},{"key":"1511_CR17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-009-1606-0","volume":"20","author":"P Bannas","year":"2010","unstructured":"Bannas P, Weber C, Derlin T, Lambert J, Leypoldt F, Adam G, et al. 18F-FDG-PET\/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. Eur Radiol. 2010;20:923\u201330.","journal-title":"Eur Radiol"},{"key":"1511_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","volume":"67","author":"A McKeon","year":"2010","unstructured":"McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010;67:322\u20139.","journal-title":"Arch Neurol"},{"key":"1511_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RLU.0b013e3182393390","volume":"37","author":"A Matsuhisa","year":"2012","unstructured":"Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H. Utility of F-18 FDG-PET\/CT in screening for paraneoplastic neurological syndromes. Clin Nucl Med. 2012;37:39\u201343.","journal-title":"Clin Nucl Med"},{"key":"1511_CR20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-013-2372-4","volume":"40","author":"N Schramm","year":"2013","unstructured":"Schramm N, Rominger A, Schmidt C, Morelli JN, Schmid-Tannwald C, Meinel FG, et al. Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG-PET\/CT and contrast-enhanced CT. Eur J Nucl Med Mol Imaging. 2013;40:1014\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1511_CR21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MNM.0b013e3283550237","volume":"33","author":"S Vaidyanathan","year":"2012","unstructured":"Vaidyanathan S, Pennington C, Ng CY, Poon FW, Han S. 18F-FDG-PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre. Nucl Med Commun. 2012;33:872\u201380.","journal-title":"Nucl Med Commun"},{"key":"1511_CR22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-016-1511-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1511-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:50Z","timestamp":1559433110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-016-1511-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s12094-016-1511-3","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2016,5,2]]}}}